Today, the Accreditation Council for Continuing Medical Education (ACCME) submitted its comments to the Centers for Medicare and Medicaid Services (CMS) regarding the executive agency's recent proposed rulemaking on the Merit-Based Incentive Payment System (MIPS) outlined in the 2015 Medicare Access and CHIP Reauthorization Act (MACRA). The ACCME's comments focus on the ways that the national CME system can support the implementation of MIPS and the improvements that the Council believes should be incorporated into a final rule.
On Thursday, June 16, the CME Coalition held a stakeholder webinar on the relevance of the Medicare Access and CHIP Reauthorization Act (MACRA) to CME and how to engage in the Centers for Medicare and Medicaid Services (CMS) comment process by the June 27 deadline. The webinar featured a presentation from Andrew Rosenberg, J.D., Senior Advisor, CME Coalition, and Thomas Sullivan, President and Founder of Rockpointe Corporation, a leading medical communications agency.
List of Acronyms Related to the Medicare Access and CHIP Reauthorization Act of 2015
ABC™ – Achievable Benchmark of Care
ACA – The Patient Protection and Affordable Care Act
ACO – Accountable Care Organization
APM – Alternative Payment Model
BPCI – Bundled Payments for Care Improvement
CAH – Critical Access Hospital
CAHPS – Consumer Assessment of Healthcare Providers and Systems
CEHRT – Certified EHR technology
CFR – Code of Federal Regulations
On May 3-4, 2016, the Food and Drug Administration (FDA) hosted a two-day long Joint Meeting of the Drug Safety and Risk Management Advisory Committee (DSaRM) and the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) to discuss results from assessments of the extended-release and long-acting (ER/LA) Opioid Analgesics REMS. The CME Coalition submitted public comments following the meeting, emphasizing that FDA should consider standardizing the REMS process, while allowing more flexibility in content. The Coalition also suggested that REMS should be expanded to include short acting opioids.
In a letter to Sen. John Barrasso (R-WY), the CME Coalition applauded the Senator for his recent introduction of legislation which appropriately exempts CME and certain educational materials from the reporting requirements of the Physician Payment Sunshine Act (Sunshine Act). As the Coalition writes to Sen. Barrsso, who is also a practicing physician, "While the Sunshine Act intended to make payments from commercial entities to physicians more transparent, we believe that the Centers for Medicare and Medicaid Services’ (CMS) has confused and misread Congressional intent, providing a mix of regulatory interpretations that have called into question whether independent, accredited CME activities could also be subject to the law’s reporting requirements... Your approach, which enjoys significant bipartisan support in the House of Representatives, and was overwhelmingly passed by that body as part of the “21st Century Cures” legislation, will help end much of the confusion among physicians and within the CME stakeholder community. We believe that your bill will reduce physician reluctance to participate in accredited CME by eliminating the “chilling effect” that exists today as a result of Open Payments reporting. We look forward to your bill’s consideration and passage by the full Senate. "